Abstract
Brown and colleagues1 reported the results of a systematic review of the literature aimed in determining whether greater extent of resection (EOR) is associated with improved 1- and 2-year overall survival and 6-month and 1-year progression-free survival in patients affected by glioblastoma multiforme. The analysis revealed 37 studies suitable for inclusion. The authors found that gross total resection (GTR) for glioblastoma multiforme reduces 1- and 2-year mortality, thus supporting GTR over subtotal resection and biopsy.
Lingua originale | English |
---|---|
pagine (da-a) | 1508-1509 |
Numero di pagine | 2 |
Rivista | JAMA oncology |
Volume | 2 |
Stato di pubblicazione | Published - 2016 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2730???
- ???subjectarea.asjc.1300.1306???